Search alternatives:
targeted therapeutics » targeted therapeutic (Expand Search), targeted therapies (Expand Search), based therapeutics (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
host resistance » plant resistance (Expand Search)
decrease host » decreases short (Expand Search)
targeted therapeutics » targeted therapeutic (Expand Search), targeted therapies (Expand Search), based therapeutics (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
host resistance » plant resistance (Expand Search)
decrease host » decreases short (Expand Search)
-
81
-
82
-
83
-
84
-
85
-
86
Plasma activated water as resistance inducer against bacterial leaf spot of tomato
Published 2019“…In the frame of a sustainable agriculture the use of bacterial antagonists, biological agents, plant defence response elicitors or resistant host plant genotypes are the most effective approaches. …”
-
87
-
88
The distribution of isolates from Indiana based on host factors and AMR status.
Published 2022Subjects: -
89
Data_Sheet_1_Quantitative proteomic analysis and replacement therapy identifies haptoglobin as a therapeutic target in a murine model of SLE-associated diffuse alveolar hemorrhage....
Published 2024“…However, the treatment options for DAH remain limited, and DAH-related studies are needed to explore more effective therapeutic directions for better disease management and improved prognosis.…”
-
90
-
91
-
92
Data_Sheet_1_Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-small Cell Lung Cancers.docx
Published 2020“…</p><p>Conclusions: Our findings support the monomerization of ALK fusion proteins using EML4cc peptides for competitive inhibition of dimerization as a promising therapeutic strategy for EML4-ALK NSCLC. Further studies are warranted to explore the use of specific cc peptide as a therapeutic option for other lung cancers harboring driver fusion genes containing a cc or oligomerization domain within the fusion partner.…”
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100